Quantum-Si to Participate in Upcoming Investment Conferences

Business Wire

05 Nov 2024

BRANFORD, Conn., November 05, 2024--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it will be participating in two upcoming investment conferences.

Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat discussion at the UBS Global Healthcare Conference on Wednesday, November 13^th, at 8:45 AM PT.

On Thursday, November 21^st at 8:00 AM ET, Mr. Hawkins will participate in a fireside chat discussion at the Canaccord Medtech, Diagnostics & Services Forum in New York City.

A live and archived webcast of the event will be available in the "Investors" section of the Quantum-Si website under Events & Presentations.

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241105331252/en/

Contacts

Investor Contact
Doug Farrell, VP, Investor Relations
ir@quantum-si.com

Media Contact
Katherine Atkinson, SVP of Commercial Marketing
media@quantum-si.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2481374683"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2481374683\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2481374683?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/vsCZ_Z3TkcqyV0KuJdHshg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/69a6f1db64183d6e21e80cf490a75c15","is_english":true,"pubTime":"2024-11-05 22:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2481374683","market":"us","top_or_hot":-1,"title":"Quantum-Si to Participate in Upcoming Investment Conferences","media":"Business Wire","content":"<html><body>\n<figure>\n<img border=\"0\" height=\"512\" src=\"https://s.yimg.com/uu/api/res/1.2/lghmWpMciP21ALc3bV1YPQ--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/business-wire.com/69a6f1db64183d6e21e80cf490a75c15\" title=\"\" width=\"1024\"/>\n<figcaption></figcaption>\n</figure>\n<p><b>BRANFORD, Conn., November 05, 2024</b>--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (\"Quantum-Si,\" \"QSI\" or the \"Company\"), The Protein Sequencing Company™, today announced that it will be participating in two upcoming investment conferences.</p>\n<p>Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat discussion at the UBS Global Healthcare Conference on Wednesday, November 13<sup>th</sup>, at 8:45 AM PT.</p>\n<p>On Thursday, November 21<sup>st</sup> at 8:00 AM ET, Mr. Hawkins will participate in a fireside chat discussion at the Canaccord Medtech, Diagnostics &amp; Services Forum in New York City.</p>\n<p>A live and archived webcast of the event will be available in the \"Investors\" section of the Quantum-Si website under Events &amp; Presentations.</p>\n<p><b>About Quantum-Si Incorporated</b></p>\n<p>Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.</p>\n<p><span>View source version on businesswire.com: </span><span>https://www.businesswire.com/news/home/20241105331252/en/</span></p>\n<p><b>Contacts</b></p>\n<p><b>Investor Contact </b><br/>Doug Farrell, <a href=\"https://laohu8.com/S/VP..UK\">VP</a>, Investor Relations<br/>ir@quantum-si.com<br/><br/></p>\n<p><b>Media Contact </b><br/>Katherine Atkinson, SVP of Commercial Marketing<br/>media@quantum-si.com<br/><br/></p></body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Quantum-Si to Participate in Upcoming Investment Conferences</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuantum-Si to Participate in Upcoming Investment Conferences\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-05 22:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/quantum-si-participate-upcoming-investment-140000584.html><strong>Business Wire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRANFORD, Conn., November 05, 2024--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (\"Quantum-Si,\" \"QSI\" or the \"Company\"), The Protein Sequencing Company™, today announced that it will be ...</p>\n\n<a href=\"https://finance.yahoo.com/news/quantum-si-participate-upcoming-investment-140000584.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://finance.yahoo.com/news/quantum-si-participate-upcoming-investment-140000584.html","article_id":"2481374683","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/vsCZ_Z3TkcqyV0KuJdHshg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/69a6f1db64183d6e21e80cf490a75c15"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481374683","pubTimestamp":1730815200,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"BRANFORD, Conn., November 05, 2024----Quantum-Si Incorporated  , The Protein Sequencing Company, today announced that it will be participating in two upcoming investment conferences.Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat discussion at the UBS Global Healthcare Conference on Wednesday, November 13th, at 8:45 AM PT.On Thursday, November 21st at 8:00 AM ET, Mr. Hawkins will participate in a fireside chat discussion at the Canaccord Medtech, Diagnostics & Services Forum in New York City.A live and archived webcast of the event will be available in the \"Investors\" section of the Quantum-Si website under Events & Presentations.Media Contact Katherine Atkinson, SVP of Commercial Marketingmedia@quantum-si.com","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"Quantum-Si将参加即将举行的投资会议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"QSI":0.9,"QSIAW":0.9},"content_text":"BRANFORD, Conn., November 05, 2024--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (\"Quantum-Si,\" \"QSI\" or the \"Company\"), The Protein Sequencing Company™, today announced that it will be participating in two upcoming investment conferences.\nJeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat discussion at the UBS Global Healthcare Conference on Wednesday, November 13th, at 8:45 AM PT.\nOn Thursday, November 21st at 8:00 AM ET, Mr. Hawkins will participate in a fireside chat discussion at the Canaccord Medtech, Diagnostics & Services Forum in New York City.\nA live and archived webcast of the event will be available in the \"Investors\" section of the Quantum-Si website under Events & Presentations.\nAbout Quantum-Si Incorporated\nQuantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20241105331252/en/\nContacts\nInvestor Contact Doug Farrell, VP, Investor Relationsir@quantum-si.com\nMedia Contact Katherine Atkinson, SVP of Commercial Marketingmedia@quantum-si.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}